Astro-Med, Inc. Directors Declare Quarterly Dividend; FY 2015 Financial Results Scheduled for March 18
Astro-Med, Inc. (NASDAQ: ALOT), a leading manufacturer of data visualization technology products for the specialty printing and test & measurement markets, will announce its fourth-quarter fiscal 2015 financial results pre-market on Wednesday, March 18, 2015 and will host a conference call starting at 9:00 a.m. ET.
The call can be accessed at Astro-Med, Inc.’s web site, www.Astro-MedInc.com. You can participate in the conference call by dialing 888-539-3638 (U.S. and Canada) or 719-457-2693 (International) with passcode 435183.
Following the live broadcast, an audio webcast of the call will be available at www.Astro-MedInc.com. A telephone replay of the conference call will be available for seven days by dialing 888-203-1112 (U.S. and Canada) or 719-457-0820 (International) with passcode 6616267.
Directors Declare Quarterly Dividend
On February 27, 2015, the Directors of Astro-Med, Inc. declared a regular quarterly cash dividend of $0.07 per share, payable on April 1, 2015, to shareholders of record March 13, 2015 for the fourth quarter, which ended on January 31, 2015.
About Astro-Med, Inc.
Astro-Med, Inc. is a global leader in data visualization technology that delivers accuracy, efficiency, speed and performance across a range of end markets. The Company’s products include color label printers and consumables sold under the QuickLabel Systems brand, rugged printers for aerospace and defense applications as well as test & measurement products sold under the Astro-Med brand. Astro-Med, Inc. is a member of the Russell Microcap® Index. Additional information is available by visiting www.Astro-MedInc.com
Forward-Looking Statements
Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. These statements may include the use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties, and factors include, but are not limited to, those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2014 and subsequent filings Astro-Med makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.
Source: Astro-Med, Inc.
Astro-Med, Inc.
Joseph P. O’Connell, 800-343-4039
Senior Vice President, Chief Financial Officer